Sign in to view content

Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy

Andrew N. Antoszyk, MD FASRS

Video
Published 2016

Related

Key Pearls of the Refill-Exchange Procedure for the Port Delivery System With Ranibizumab (PDS)
Jordan M. Graff, MD, FACS
Annual Meeting Talks
2021
Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017
Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more
Jayanth Sridhar, MD
Daniel L Chao, MD, PhD
Ferhina S Ali, MD, MPH
Member Podcasts
2020

Category: Diabetic Retinopathy

See more